In fact, early treatment with riboflavin was reported to have reduced the severity of symptoms in an 8-year-old child with a homozygous nonsense mutation in FLAD1, that showed aberrant biochemical results in the newborn screening test for MADD [75]. The gene discussed is FLAD1; the disease is multiple acyl-CoA dehydrogenase deficiency.